Sam Chun Dang Pharm. Co. Ltd (000250) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.044x

Based on the latest financial reports, Sam Chun Dang Pharm. Co. Ltd (000250) has a cash flow conversion efficiency ratio of -0.044x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-15.17 Billion ≈ $-10.28 Million USD) by net assets (₩343.90 Billion ≈ $233.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sam Chun Dang Pharm. Co. Ltd (000250) defensive interval to measure how many days the company can operate on defensive assets alone.

Sam Chun Dang Pharm. Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Sam Chun Dang Pharm. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sam Chun Dang Pharm. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sam Chun Dang Pharm. Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Global Health Limited NSE:MEDANTA	0.082x
Cal-Maine Foods Inc NASDAQ:CALM	0.038x
Ningbo Zhenyu Technology Co. Ltd. SHE:300953	0.016x
Micro-Star International Co Ltd TW:2377	0.022x
Beijing Shougang Co Ltd SHE:000959	0.059x
Otter Tail Corporation NASDAQ:OTTR	0.037x
Airoha Technology Corp TW:6526	0.071x
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	0.039x

Annual Cash Flow Conversion Efficiency for Sam Chun Dang Pharm. Co. Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Sam Chun Dang Pharm. Co. Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 000250 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩266.11 Billion ≈ $180.34 Million	₩21.77 Billion ≈ $14.75 Million	0.082x	+4.22%
2023-12-31	₩298.46 Billion ≈ $202.26 Million	₩23.43 Billion ≈ $15.88 Million	0.078x	+2.70%
2022-12-31	₩173.74 Billion ≈ $117.74 Million	₩13.28 Billion ≈ $9.00 Million	0.076x	+272.65%
2021-12-31	₩174.09 Billion ≈ $117.98 Million	₩-7.71 Billion ≈ $-5.22 Million	-0.044x	-354.23%
2020-12-31	₩186.63 Billion ≈ $126.47 Million	₩3.25 Billion ≈ $2.20 Million	0.017x	-91.02%
2019-12-31	₩157.87 Billion ≈ $106.99 Million	₩30.60 Billion ≈ $20.74 Million	0.194x	+15.00%
2018-12-31	₩148.52 Billion ≈ $100.65 Million	₩25.03 Billion ≈ $16.97 Million	0.169x	-8.68%
2017-12-31	₩141.34 Billion ≈ $95.78 Million	₩26.09 Billion ≈ $17.68 Million	0.185x	+30.05%
2016-12-31	₩125.17 Billion ≈ $84.82 Million	₩17.76 Billion ≈ $12.04 Million	0.142x	-6.45%
2015-12-31	₩114.32 Billion ≈ $77.47 Million	₩17.34 Billion ≈ $11.75 Million	0.152x	+8.38%
2014-12-31	₩139.68 Billion ≈ $94.66 Million	₩19.55 Billion ≈ $13.25 Million	0.140x	+4.69%
2013-12-31	₩119.23 Billion ≈ $80.80 Million	₩15.94 Billion ≈ $10.80 Million	0.134x	+622.90%
2012-12-31	₩86.63 Billion ≈ $58.71 Million	₩1.60 Billion ≈ $1.09 Million	0.018x	--

About Sam Chun Dang Pharm. Co. Ltd

KQ:000250 Korea Pharmaceuticals

Market Cap

$3.68 Billion

₩5.43 Trillion KRW

Market Cap Rank

#4406 Global

#108 in Korea

Share Price

₩253500.00

Change (1 day)

-3.61%

52-Week Range

₩144400.00 - ₩1000000.00

All Time High

₩1000000.00